Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)

被引：0
|
作者：
Schuchardt, C. [1 ]
Kulkarni, H. R. [1 ]
Wiessalla, S. [1 ]
Shahinfar, M. [1 ]
Shafaei, S. [1 ]
Kropf, S. [2 ]
Wester, H. J. [3 ,4 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka GmbH, THERANOST Ctr Mol Radiotherapy & Mol Imaging, Bad Berka, Germany
[2] Scintomics GmbH, Fuerstenfeldbruck, Germany
[3] Tech Univ Munich, Fac Chem, D-80290 Munich, Germany
[4] Tech Univ Munich, Fac Med, D-80290 Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP291
引用
收藏
页码：S224 / S225
页数：2
相关论文
共 50 条
  • [31] Short-term Haematological and Biochemical Safety of Lu-177 DOTATATE Therapy
    Kauppila, E.
    Allen, R.
    Ifigeneia, K.
    Meades, R.
    Tan, T.
    Barwick, T.
    Soneji, N.
    Al-Nahhas, A.
    Win, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S587 - S587
  • [32] Assessment of Thyroid and Breast Radiation Absorbed Doses in Lu-177 DOTATATE Therapy Using Voxel Dosimetry
    Alandnosi, Fyrooz
    Alrasheedi, Mohammed
    Brady, Amy
    George, Remo
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [33] Induction and Maintenance Regimen with Peptide Receptor Radionuclide Therapy (PRRT) Lu-177-DOTA-TATE (Lu-177) in Patients with Advanced Neuroendocrine Tumours (NET)
    Mc Ewan, A.
    Wieler, M.
    Makis, W.
    McMullen, T.
    Morrish, D.
    MacLeod, S.
    Schrader, L.
    Sawyer, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 94 - 94
  • [34] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Staanum, Peter Frohlich
    Frellsen, Anders Floor
    Olesen, Marie Louise
    Iversen, Peter
    Arveschoug, Anne Kirstine
    EJNMMI PHYSICS, 2021, 8 (01)
  • [35] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Peter Frøhlich Staanum
    Anders Floor Frellsen
    Marie Louise Olesen
    Peter Iversen
    Anne Kirstine Arveschoug
    EJNMMI Physics, 8
  • [36] Renal Clearance in NET-Patients before and after PRRT with Y-90 DOTATATE and Lu-177 DOTATATE
    Helms, F.
    Felsch, P.
    Knapp, W. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S500 - S500
  • [37] Dosimetry in peptide receptor Radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and interpatient variability
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S178 - S179
  • [38] Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy
    Abbott, Amanda
    Jacene, Heather
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2018, 46 (03) : 245 - 246
  • [39] Off-label usage of Lu-177 DOTATATE therapy : Challenges and Opportunities for the Theranostician
    Muthukrishnan, Ashok
    Pakala, Theja
    Srinivas, Shyam
    Nguyen, Nghi
    Drappatz, Jan
    Snyderman, Carl
    Gorantla, Vikram
    Bahary, Nathan
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [40] Radiation Exposure to Children and Others During Therapy for Pediatric Neuroblastoma With Lu-177 DOTATATE
    Lu, Z.
    Sun, X.
    Sun, Y.
    Zuo, D.
    Li, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S44 - S44
12345